ZILA REPORTS HIGHER NET REVENUES FOR 3RD QTR FISCAL
'02.(Brief Article)
Zila, Inc. (Nasdaq:ZILA), Phoenix, Ariz., international provider of
healthcare and biotechnology products and services for dental/medical
professionals and consumers, has reported higher net . . .
RIBAPHARM REPORTS INCREASE IN FIRST QTR 2002 NET INCOME.(Brief
Article)(Statistical Data Included)
Ribapharm Inc. (NYSE: RNA), Costa Mesa, Calif., has reported first
quarter 2002 net income of $30 million, an increase from $15 million
compared to the same period in 2001. In addition, the company . . .
BIO-LOGIC REPORTS NEARLY 24% SALES INCREASE FOR FISCAL
2002.(Statistical Data Included)
Bio-logic Systems Corp. (Nasdaq: BLSC), Mundelein, Ill., a designer
and marketer of computerized medical electro-diagnostic equipment and
disposables, has reported financial results for the fourth . . .
NORTH AMERICAN SCIENTIFIC REPORTS 6% INCREASE IN SALES.(Brief
Article)(Statistical Data Included)
North American Scientific, Inc. (Nasdaq:NASI), Chatsworth, Calif.,
has announced financial results for its second quarter ended April 30,
2002. The company also announced that it has recorded . . .
DIGIRAD REPORTS 42% REVENUE INCREASE FOR FIRST QTR 2002.(Brief
Article)(Statistical Data Included)
Digirad Corporation, San Diego, the leader in solid-state gamma
camera technology and the premier nuclear imaging services provider, has
reported record revenue achievements for the twelve months . . .
EXACT SCIENCES REPORTS NET LOSS OF 7.6 MILLION FOR FIRST
QTR.(Applied genomics company reports financial results for first
quart
EXACT Sciences Corporation (NASDAQ: EXAS), Maynard, Mass., has
announced financial results for the first quarter ending March 31, 2002.
For the quarter ending March 31, 2002, net loss totaled . . .
BONE CARE REPORTS NET LOSS OF $1,781,000 FOR 3RD QTR.(Revenues
rose to $3,775,000 for quarter ended March 31, 2002)(Brief
Articl
Bone Care International, Inc. (NASDAQ: BCII), Middleton, Wis., has
announced that revenues for the quarter ended March 31, 2002 increased
to $3,775,000 from $2,009,000 in the quarter ended March . . .
NOVOSTE REPORTS 146% SALES INCREASE FOR FIRST QUARTER.(Reports
sales of $22.9 mn for quarter ended March 31, 2002)(Brief
Article
Novoste Corporation (NASDAQ: NOVT) has reported its financial
results for the quarter ended March 31, 2002.
The company reported all time record sales of $22.9 million,
compared to $9.3 million . . .
THERAGENICS REPORTS NET INCOME DECREASED 40% FOR FIRST
QTR.(Reports revenue and earnings for first quarter ending March 31,
2002
Theragenics Corporation(R) (NYSE: TGX), the Georgia-based cancer
treatment producer, has announced revenue and earnings for the first
quarter ending March 31, 2002.
Revenues for the quarter were . . .
EPOCH BIOSCIENCES REPORTS INCREASED FIRST QTR. REVENUES.(Reports
revenues rose to $2.3 mn for first quarter)(Brief Article)(Stat
Epoch Biosciences, Inc. (Nasdaq: EBIO), Bothell, Wash., a provider
of proprietary products that accelerate genomic analysis, has reported
revenues for the first quarter increased to $2.3 million . . .
GENENTECH REPORTS 22% INCREASE IN FIRST QTR PRODUCT SALES.(Brief
Article)
Genentech, Inc. (NYSE:DNA), South San Francisco, has announced
first quarter pro forma financial results of a 29 percent increase in
earnings per share from the first quarter of 2001 driven by a 22 . . .
TITAN REPORTS INCREASE IN REVENUE FOR FISCAL YEAR.(Titan
Pharmaceuticals, Inc. )(Brief Article)
Titan Pharmaceuticals, Inc. (ASE: TTP), South San Francisco, has
announced financial results for the fourth quarter and fiscal year ended
December 31, 2001.
Revenues for fourth quarter 2001 were . . .
EP MEDSYSTEMS REPORTS INCREASED SALES FOR 4TH QTR.(Brief
Article)(Statistical Data Included)
EP MedSystems, Inc. (NASDAQ: EPMD), Mt. Arlington, N.J., has
announced sales for the fourth quarter totaled $2,967,000 as compared to
$2,004,000 in 2000 and $2,483,000 for the third quarter 2001.
. . .
COLUMBIA LABORATORIES REPORTS LOSS FOR 4TH QUARTER.(Brief
Article)(Statistical Data Included)
Columbia Laboratories (AMEX:COB), Livingston, N.J., has reported a
loss for the fourth quarter ended December 31, 2001 of $4,356,067, or
$0.14 per share, on sales of $160,778, as compared to a net . . .
OPHTHALMIC IMAGING REPORTS 60% INCREASE IN NET REVENUES.(Brief
Article)(Statistical Data Included)
Ophthalmic Imaging Systems ("OIS") (OTCBB:OISI),
Sacramento, Calif., has reported its financial results for the year
ended December 31, 2001.
The company's net revenues for fiscal 2001 were . . .
BIOSOURCE REPORTS A 19% INCREASE IN 4TH QTR SALES.(4th-quarter
earnings report)(Statistical Data Included)
BioSource International, Inc. (Nasdaq:BIOI), Camarillo, Calif., has
announced its operating results for the quarter and year ended December
31, 2001 and its 2002, 2003 and 2004 outlook.
Net sales . . .
GENE LOGIC REVENUES INCREASED 49% FOR 4TH QTR 2001.(4th-quarter
earnings report)(Brief Article)(Statistical Data Included)
Gene Logic Inc. (Nasdaq:GLGC), Gaithersburg, Md., a provider of
genomics-based information products and services, reported its fourth
quarter and year end 2001 financial results.
Record revenue . . .
ALBANY MOLECULAR REPORTS 4TH QTR 2001 NET INCOME UP
24%.(4th-quarter earnings report)(Statistical Data Included)
Albany Molecular Research, Inc. (NASDAQ: AMRI), Albany,N.Y., has
announced operating results for the quarter and year ended December 31,
2001.
Total revenue for the fourth quarter 2001 increased . . .
INHALE REPORTS INCREASE IN REVENUES FOR 4TH QTR/YEAR END.(Brief
Article)(Statistical Data Included)
Inhale Therapeutic Systems, Inc., San Carlos, Calif., (Nasdaq:INHL)
has announced its financial results for the fourth quarter and the year
ended December 31, 2001. The company reported revenue of . . .
UROLOGIX REPORTS 65% INCREASE IN 2ND QTR FISCAL 2002
REVENUES.(Brief Article)(Statistical Data Included)
Urologix, Inc. (NASDAQ:ULGX), Minneapolis, has reported financial
results for the second quarter of fiscal 2002 ended December 31, 2001.
Revenue for the second quarter was $5.3 million, . . .
|
|